825. Laboratory Monitoring in HIV: What, When and What’s New
Session: Symposium: State-of-the-Art in HIV
Saturday, October 22, 2011: 8:45 AM
Room: 210ABC

Michael Horberg, MD MAS, Kaiser Permanente Medical Care Program, Oakland, CA

Michael Alan Horberg, MD, MAS, FACP is Executive Director Research of Mid-Atlantic Permanente Medical Group (MAPMG) and the director of the Mid-Atlantic Permanente Research Institute (MAPRI). He is also director of HIV/AIDS for Kaiser Permanente. Dr. Horberg has been appointed to serve on the Presidential Advisory Council on HIV/AIDS (PACHA), and co-chairs the Access to Care and Improved Outcomes Committee of PACHA. Dr. Horberg is a Fellow of the American College of Physicians, and he presently serves as Vice-Chair of the Board of Directors of the HIV Medicine Association of the Infectious Disease Society of America. He has co-chaired the NCQA/AMA/HRSA/IDSA sponsored Expert Panel on HIV-related provider performance measures. He is Assistant Clinical Professor at Stanford University Medical School. Dr. Horberg is past-president of the national Gay and Lesbian Medical Association. His HIV research interests are health service outcomes for HIV-infected patients (including HIV quality measures and care improvement, and determinants of optimized multidisciplinary care for maximized HIV outcomes), medication adherence issues in these patients, and epidemiology of the disease. He graduated from Boston University’s College of Liberal Arts and School of Medicine (with honors of Summa cum Laude and Phi Beta Kappa) and completed his internal medicine residency at Michael Reese Hospital in Chicago (University of Chicago affiliate). He received his Master of Advanced Studies (Clinical Research) from University of California San Francisco.

See more of: State-of-the-Art in HIV
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.